Infectious Diseases (Notification of Infectious Diseases) (Amendment) Regulations 2019

No. S 163

Infectious Diseases Act

(CHAPTER 137)

Infectious Diseases
(Notification of Infectious Diseases)
(Amendment) Regulations 2019

In exercise of the powers conferred by section 73(1) of the Infectious Diseases Act, the Minister for Health makes the following Regulations:

Citation and commencement

1. These Regulations are the Infectious Diseases (Notification of Infectious Diseases) (Amendment) Regulations 2019 and come into operation on 25 March 2019.

Amendment of regulation 1

2. Regulation 1 of the Infectious Diseases (Notification of Infectious Diseases) Regulations 2008 (G.N. No. S 612/2008) (called in these Regulations the principal Regulations) is amended by inserting, immediately after the words “Notification of”, the word “Prescribed”.

Amendment of regulation 2

3. Regulation 2 of the principal Regulations is amended by deleting the words “infectious diseases” and substituting the words “prescribed infectious diseases”.

Amendment of regulation 3

4. Regulation 3 of the principal Regulations is amended —

(a)

by deleting the words “an infectious disease” in paragraph (1) and substituting the words “a prescribed infectious disease”;

(b)

by inserting, immediately after paragraph (2), the following paragraph:

“(3) Every notification under section 6(1), (2) and (3) of the Act must be given by fax or through the electronic notification system.”; and

(c)

by inserting, immediately after the word “Form” in the regulation heading, the words “and manner”.

Amendment of regulation 4

5. Regulation 4 of the principal Regulations is amended by deleting the words “an infectious disease mentioned in the Schedule” and substituting the words “a prescribed infectious disease”.

Deletion and substitution of regulation 5 and new regulation 5A

6. Regulation 5 of the principal Regulations is deleted and the following regulations substituted therefor:

“Time for notification by medical practitioner

5.—(1) For the purposes of section 6(1) of the Act, the prescribed time for notification by a medical practitioner is as follows:

(a)

where the medical practitioner has reason to believe or suspects that a person attended or treated by the medical practitioner is suffering from, or is a carrier of, a prescribed infectious disease mentioned in the second column of Part 1 or 2 (as the case may be) of the Schedule — the time specified in the third column of that Part that corresponds to that prescribed infectious disease, starting when the medical practitioner so believes or suspects; and

(b)

where a medical practitioner —

(i)	has reason to believe or suspects that a person attended or treated by the medical practitioner is suffering from, or is a carrier of, a prescribed infectious disease mentioned in the second column of Part 1 or 3 (as the case may be) of the Schedule; and
(ii)	during the attendance or treatment, performs a diagnostic test on that person and becomes aware that the person is suffering from, or is a carrier of, that prescribed infectious disease,

the time specified in the third column of that Part that corresponds to that prescribed infectious disease, starting when the medical practitioner becomes so aware.

(2) For the purposes of section 6(3)(b) of the Act and subject to paragraph (3), the prescribed time for notification by a medical practitioner who is aware or suspects that a person has died while suffering from, or being a carrier of, a prescribed infectious disease mentioned in the second column of Part 1 or 2 (as the case may be) of the Schedule is the time specified in the third column of that Part that corresponds to that prescribed infectious disease, starting when the medical practitioner becomes so aware or suspects.

(3) To avoid doubt, paragraph (2) does not apply if the medical practitioner had notified the Director under section 6(1) of the Act that the medical practitioner had reason to believe or suspect that the person was suffering from, or was a carrier of, the prescribed infectious disease.

Time for notification by person in charge of laboratory

5A. For the purposes of section 6(2) of the Act, the prescribed time for notification by a person in charge of a laboratory who becomes aware of the existence of a prescribed infectious disease mentioned in the second column of Part 1 or 3 (as the case may be) of the Schedule is the time specified in the third column of that Part that corresponds to that prescribed infectious disease, starting when the person becomes so aware.”.

Deletion and substitution of Schedule

7. The Schedule to the principal Regulations is deleted and the following Schedule substituted therefor:

“THE SCHEDULE

Regulations 5 and 5A

NOTIFICATION OF PRESCRIBED INFECTIOUS DISEASES

Part 1

First column

Second column

Third column

Notification under following regulations

Prescribed infectious disease

Prescribed time for notification

1.	Regulation 5(1)(a)

2.	Regulation 5(1)(b)

3.	Regulation 5(2)

4.	Regulation 5A

(a)	Avian Influenza

(b)

Botulism

(c)	Chikungunya Fever

(d)	Dengue Fever

(e)	Dengue Haemorrhagic Fever

(f)	Diphtheria

(g)	Ebola Virus Disease (EVD)

(h)	Japanese Encephalitis

(i)

Malaria

(j)

Measles

(k)	Middle Eastern Respiratory Syndrome Coronavirus Infection (MERS‑CoV)

(l)	Nipah Virus

(m)

Plague

(n)	Poliomyelitis

(o)

Rabies

(p)

Rubella

(q)	Severe Acute Respiratory Syndrome (SARS)

(r)	Yellow Fever

(s)	Zika Virus Infection

Not later than 24 hours

(a)

Mumps

(b)

Syphilis

(c)	Tuberculosis

Not later than 72 hours

Part 2

First column

Second column

Third column

Notification under following regulations

Prescribed infectious disease

Prescribed time for notification

1.	Regulation 5(1)(a)

2.	Regulation 5(2)

Tetanus

Not later than 72 hours

Part 3

First column

Second column

Third column

Notification under following regulations

Prescribed infectious disease

Prescribed time for notification

1.	Regulation 5(1)(b)

2.	Regulation 5A

(a)

Cholera

(b)	Haemophilus Influenzae Type b (Hib) Disease

(c)	Leptospirosis

(d)	Meningoccocal Disease

(e)	Murine Typhus

(f)	Paratyphoid

(g)

Typhoid

Not later than 24 hours

(a)	Acute Hepatitis A

(b)	Acute Hepatitis B

(c)	Acute Hepatitis C

(d)	Acute Hepatitis E

(e)	Campylobacteriosis

(f)	Chlamydial Genital Infection

(g)	Gonorrhoea

(h)	HIV Infection

(i)

Leprosy

(j)	Legionellosis

(k)	Melioidosis

(l)

Pertussis

(m)	Pneumococcal Disease (Invasive)

(n)	Salmonellosis

Not later than 72 hours

”.

[G.N. Nos. S 175/2009; S 619/2010; S 521/2014; S 36/2016, S 450/2016; S 225/2018]

Made on 22 March 2019.

NG HOW YUE

Second Permanent Secretary,
Ministry of Health,
Singapore.

[MOH 78:25 Vol 52; AG/LEGIS/SL/137/2015/7 Vol. 1]

Search within Legislation